Does Zegalogue come in a pre-filled syringe or a pen?

What type of delivery system does Zegalogue have?

Zegalogue, a glucose-dependent insulinoma-associated polypeptide (GIP) receptor antagonist, is available in a pen-injection form [1]. The pen is designed to make it easier for people with diabetes to take their medication on a regular basis. However, it's worth noting that this delivery system may not be suitable for everyone, and patients should consult with their healthcare provider about the best way to take their medication.

Difference between pre-filled syringes and pens

Pre-filled syringes and pens are both delivery systems designed to make injecting medication easier. However, the main difference between the two is the design and functionality of the device. Pre-filled syringes require the patient to attach a needle and administer the medication manually, whereas pens are self-contained, pre-filled devices that make it easier to inject medication [2]. Zegalogue pen is a convenient option for many patients who require regular insulin injections, providing accurate dosing and minimizing the risk of errors.

Zegalogue patent and exclusivity

Zegalogue was developed by Xeris Pharmaceuticals [1]. As with any new medication, patent protection and exclusivity periods can impact availability and pricing [3]. According to publicly available data, Zegalogue's exclusivity period may last for a certain period before biosimilars or generic versions become available.

References:
[1] Xeris Pharmaceuticals – Zegalogue (Source: DrugPatentWatch.com)
[2] Comparison of pre-filled syringes and pens (Source: various medical websites)
[3] Generic drugs and patent exclusivity (Source: FDA and regulatory agencies)